Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Manas Upadhyaya
Angioedema Secondary to IV Tissue Plasminogen Activator Administration for Treatment of Acute Ischemic Stroke
Case Reports in Critical Care
Related publications
Systemic Review : Role of Tissue Plasminogen Activator for Acute Ischemic Stroke
The Egyptian Journal of Hospital Medicine
Tissue Plasminogen Activator-Based Nanothrombolysis for Ischemic Stroke
Expert Opinion on Drug Delivery
Pharmaceutical Science
Should the Window for Intravenous Administration of Tissue Plasminogen Activator in the Treatment of Acute Ischemic Stroke Be Extended to 4.5 Hours?
Canadian Journal of Hospital Pharmacy
Pharmacology
Pharmacy
Genome Response to Tissue Plasminogen Activator in Experimental Ischemic Stroke
BMC Genomics
Biotechnology
Genetics
Pharmacotherapy Updates of Recombinant Tissue Plasminogen Activator (R-Tpa) in Acute Ischemic Stroke
Jentashapir Journal of Health Research
Hemostatic Activation and Outcome After Recombinant Tissue Plasminogen Activator Therapy for Acute Ischemic Stroke
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing
Does Intravenous Administration of Recombinant Tissue Plasminogen Activator for Ischemic Stroke Can Cause Inferior Myocardial Infarction?
Neurology International
Neurology
Physician Knowledge of the Benefits, Risks, and Contraindications of Tissue Plasminogen Activator for Acute Ischemic Stroke
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing
Cost-Effectiveness of Recombinant Tissue-Type Plasminogen Activator Within 3 Hours of Acute Ischemic Stroke
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing